Quantum BioPharma Ltd. (QNTM) — This stock currently has no analyst coverage. No price targets, ratings, or earnings estimates are available. This is common for preferred shares, warrants, OTC-traded securities, and smaller companies that are not followed by Wall Street analysts.
Analysts estimate Earnings Per Share (EPS) of $-3.18 and revenue of $0.00B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $-12.49 vs est $-3.18 (missed -292.6%). 2025: actual $-8.11 vs est $-8.28 (beat +2.1%). Analyst accuracy: 62%.
